JP2002501526A5 - - Google Patents

Download PDF

Info

Publication number
JP2002501526A5
JP2002501526A5 JP1999500546A JP50054699A JP2002501526A5 JP 2002501526 A5 JP2002501526 A5 JP 2002501526A5 JP 1999500546 A JP1999500546 A JP 1999500546A JP 50054699 A JP50054699 A JP 50054699A JP 2002501526 A5 JP2002501526 A5 JP 2002501526A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1999500546A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002501526A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/NZ1998/000070 external-priority patent/WO1998054226A1/en
Publication of JP2002501526A publication Critical patent/JP2002501526A/ja
Publication of JP2002501526A5 publication Critical patent/JP2002501526A5/ja
Ceased legal-status Critical Current

Links

JP50054699A 1997-05-29 1998-05-29 乳汁における免疫グロブリンaの生成方法 Ceased JP2002501526A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NZ31495997 1997-05-29
NZ314959 1997-05-29
PCT/NZ1998/000070 WO1998054226A1 (en) 1997-05-29 1998-05-29 Processes for production of immunoglobulin a in milk

Publications (2)

Publication Number Publication Date
JP2002501526A JP2002501526A (ja) 2002-01-15
JP2002501526A5 true JP2002501526A5 (enExample) 2005-12-08

Family

ID=19926267

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50054699A Ceased JP2002501526A (ja) 1997-05-29 1998-05-29 乳汁における免疫グロブリンaの生成方法

Country Status (9)

Country Link
US (3) US6616927B2 (enExample)
EP (1) EP0990001B1 (enExample)
JP (1) JP2002501526A (enExample)
AT (1) ATE325817T1 (enExample)
AU (1) AU738888B2 (enExample)
BR (1) BR9809186A (enExample)
CA (1) CA2291487A1 (enExample)
DE (1) DE69834490T2 (enExample)
WO (1) WO1998054226A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ15898A3 (cs) * 1998-01-19 1999-11-17 Medipharm Cz, S. R. O. Perorální přípravek k prevenci a léčbě infekčních gastroenteritid telat
US20020009429A1 (en) * 1999-01-29 2002-01-24 Galagen, Inc. Pharmaceutical composition comprising a selected antigen and candida species antigen and methods
ES2258483T3 (es) * 1999-11-01 2006-09-01 Mucovax Holding B.V Produccion de anticuerpos de secrecion mamaria en animales de granja.
US7074454B1 (en) 1999-11-01 2006-07-11 Mucovax Holding B.V. Production of mammary secretion antibodies in farm animals
US6974573B2 (en) * 1999-11-01 2005-12-13 Mucovax Holdings, B.V. Antibody production in farm animals
AU2002239159A1 (en) * 2001-03-12 2002-09-24 Rijksuniversiteit Groningen Modulation of a balance between the gut mucosal immune system and the intestinal microflora
WO2003055502A1 (en) * 2001-12-24 2003-07-10 Fonterra Co-Operative Group Limited Immunoglobulin composition
ES2544477T3 (es) 2003-10-03 2015-08-31 3M Innovative Properties Company Imidazoquinolinas sustituidas con alcoxi
FI116904B (fi) * 2003-10-21 2006-03-31 Suomen Rehu Oy Menetelmä maidon koostumuksen muuttamiseksi ja maidon käyttö
US20070065518A1 (en) * 2003-10-22 2007-03-22 Harry Leneau Colostrum compositions and methods
FR2861306B1 (fr) * 2003-10-28 2008-07-04 Vivafeed Utilisation du shiitake pour augmenter le taux d'immunoglobulines laitieres
RU2409576C2 (ru) 2003-11-25 2011-01-20 3М Инновейтив Пропертиз Компани Системы, содержащие имидазольное кольцо с заместителями, и способы их получения
NZ530709A (en) * 2004-01-21 2006-07-28 Agres Ltd Improved IGA production method
JP2008526752A (ja) * 2004-12-30 2008-07-24 スリーエム イノベイティブ プロパティズ カンパニー 免疫応答調節剤化合物の多経路投与
US9248127B2 (en) 2005-02-04 2016-02-02 3M Innovative Properties Company Aqueous gel formulations containing immune response modifiers
EP1879908B1 (en) * 2005-05-10 2014-01-08 Murray Goulburn Co-Operative Co Limited Immunoglobulin fraction and process therefor
NZ568433A (en) * 2005-10-21 2012-07-27 Gtc Biotherapeutics Inc Milk-derived antibodies with enhanced antibody-dependent cellular cytoxicity activity, methods of their production and use
US20100303830A1 (en) * 2007-12-11 2010-12-02 Nestec S.A. PREVENTION AND TREATMENT OF OTITIS MEDIA USING IgA ENRICHED MILK
EP2138187A1 (en) * 2008-06-24 2009-12-30 Nestec S.A. Probiotics, secretory IgA and infection
WO2010050829A1 (en) * 2008-10-31 2010-05-06 Vialactia Biosciences (Nz) Limited Marker assisted selection of a mammalian subject for desired immunoglobulin phenotype
PH12013501040A1 (en) 2010-11-23 2022-10-24 Pantheryx Inc Compositions and methods for treatment in broad-spectrum, undifferentiated or mixed clinical applications
BR112015019341A2 (pt) 2013-02-13 2017-08-22 Lab Francais Du Fractionnement Anticorpo anti-tnf-alfa, composição que compreende o anticorpo, método para produzir uma população de anticorpos, células epiteliais da glândula mamária, mamífero não humano transgênico, e, composição de anticorpo anti-tnf monoclonal
EP2956003A2 (en) 2013-02-13 2015-12-23 Laboratoire Français du Fractionnement et des Biotechnologies Proteins with modified glycosylation and methods of production thereof
US12263192B2 (en) 2019-02-26 2025-04-01 Pantheryx, Inc. Compositions for management of disorders of the gastrointestinal tract

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH627079A5 (en) * 1977-04-15 1981-12-31 Nestle Sa Process for preparing a protein concentrate containing immunological factors of milk origin
US4229342A (en) 1977-05-18 1980-10-21 Rhone-Poulenc Industries Process for extracting proteins from milk using silica and anion exchange resins
FR2520235A1 (fr) 1982-01-27 1983-07-29 Bel Fromageries Procede de separation d'immunoglobulines a partir de colostrum
US4971794A (en) * 1982-09-02 1990-11-20 Unilever Patent Holdings B.V. Production of antibodies using a mixture of strains of E. coli collectively expressing type I pili, CFA I pili, CFA II pili and K88 pili
DE3432718C1 (de) 1984-09-06 1986-05-22 Biotest Pharma GmbH, 6000 Frankfurt Verfahren zur Herstellung einer Loesung von Milch- und/oder Kolostralimmunglobulinen
US5066491A (en) 1985-04-15 1991-11-19 Protein Technology, Inc. Method of disease treatment utilizing an immunologically active whey fraction
FR2584727B1 (fr) 1985-07-11 1988-06-17 Roussel Uclaf Procede d'extraction de proteines du lait, produits, application du procede, et compositions pharmaceutiques
US5013824A (en) * 1985-11-19 1991-05-07 Schering Corporation Human interleukin-4 peptides and conjugates thereof
US5057540A (en) * 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
GB8729031D0 (en) 1987-12-11 1988-01-27 Express Foods Group Ltd Isolation of immunoglobulin rich fraction from whey
US5001230A (en) * 1988-02-18 1991-03-19 Schering Corporation T cell activation markers
US5258178A (en) 1990-07-30 1993-11-02 Abbott Laboratories Method and product for the treatment of gastric disease
IE76730B1 (en) 1990-07-30 1997-11-05 Abbott Laboraties Method and product for the treatment of gastric disease
NZ239466A (en) 1990-08-17 1993-12-23 Us Agriculture Desalted colostrum: spray dried product from retentate of
US5418137A (en) * 1991-09-26 1995-05-23 Paravax, Inc. Flea membrane binding site proteins as screening tools
US5155213A (en) * 1991-10-28 1992-10-13 Eloy Padron Method for isolating IgAs in the feces
US5650173A (en) * 1993-11-19 1997-07-22 Alkermes Controlled Therapeutics Inc. Ii Preparation of biodegradable microparticles containing a biologically active agent
US6592905B1 (en) 1996-01-31 2003-07-15 Massey University Production of an immunoglobulin enriched fraction from whey protein solutions

Similar Documents

Publication Publication Date Title
JP2002502276A5 (enExample)
JP2001524231A5 (enExample)
JP2000509912A5 (enExample)
JP2000507042A5 (enExample)
JP2000510751A5 (enExample)
JP2000509942A5 (enExample)
JP2000507369A5 (enExample)
JP2002503335A5 (enExample)
JP2000507433A5 (enExample)
JP2001525877A5 (enExample)
JP2000510793A5 (enExample)
JP2000508022A5 (enExample)
JP2001518988A5 (enExample)
JP2000508841A5 (enExample)
JP2001524814A5 (enExample)
JP2002514347A5 (enExample)
JP2000508680A5 (enExample)
JP2000510247A5 (enExample)
JP2000510969A5 (enExample)
JP2002501526A5 (enExample)
JP2000508102A5 (enExample)
JP2000508836A5 (enExample)
JP2001511977A5 (enExample)
JP2000507434A5 (enExample)
JP2001509172A5 (enExample)